Envoy Medical, Inc. (COCH) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.38M |
| Enterprise Value | 12.56M |
| P/E Ratio | -1.11 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 75.36 |
| Price/Book Ratio | 23.62 |
| Enterprise/Revenue | -15.79 |
| Enterprise/EBITDA | 0.15 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -113.05 |
| Operating Margin | -114.11 |
AD
Management Effectiveness
| Return On Assets | -0.98 |
| Return On Equity | 17.2 |
Income Statement
| Revenue | 241,000 |
| Revenue/Share | 0 |
| Gross Profit | -633,000 |
| EBITDA | -21.86M |
| Net Income | -23.76M |
| Diluted EPS | -1.23 |
Balance Sheet
| Total Cash | 19.68M |
| Total Cash/Share | 0.19 |
| Total Debt | 810,000 |
| Total Debt/Equity | 0.25 |
| Current Ratio | 1.73 |
| Book Value Per Share | 0.03 |
Price History
| 52-Week Change | -33.04 |
| 52-Week High | 1.89 |
| 52-Week Low | 0.36 |
| Moving Average 50 Days | 0.7 |
| Moving Average 200 Days | 0.7 |
Statistics
| Average Volume | 390,609 |
| Shares Outstanding | 20.8M |
| % Held by Institutions | 25.72 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.06 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
